Effect of Treatment with Local Administration of Dendritic Cells Combination Radiotherapy on the Expression of Bcl-2 and Bax in Renal Tumor Bearing Mice

HUANG Jian-hua,L(U) Hai-yan,ZHANG Ai-qun,WANG Yao,GUO Jia,YANG Jun,MA Li,Li Qiao
DOI: https://doi.org/10.3969/j.issn.1673-5269.2007.04.007
2007-01-01
Abstract:OBJECTIVE:To study the mechanism and efficacy of dendritic cell (DC)-based immunotherapy for renal carcinoma enhanced by radiotherapy (RT). METHODS: Renal carcinoma barring mice were treated with intratumoral (i.t) injections of bone marrow-derived unpulsed DCs combination with local fractionated tumor irradiation. BALB/c mice were inoculated s.c. in the right oxter with 2.5×106 Renca tumor cells on day 0, Renca tumors were locally irradiated on days 12-16. Unpulsed DCs (106) were administered i.t. on days 11, 15, 19 and 22. The mice were euthanized on day 28,and the growth rate, weight and size of tumor mass were measured.The expressions of Bcl-2 and Bax protein in tumors were assayed by Western blot.RESULTS: In Renca bearing mice, i.t DC alone had no antitumor effect, while RT alone had a modest but significant effect compared with the control mice, P0.05. The combination of DC and RT had a synergistic effect in inhibition of Renca tumor growth vs all other groups, P0.01. The expression level of Bax was remarkably increased, and the expression level of Bcl-2 Protein was significantly decreased. CONCLUSIONS: The DC administration combined with RT induces a potent antitumor response in tumor-bearing mice. The data suggeste that the effect of antitumor responsed in tumor-barring mice involves in the mechanism of tumor apoptosis.
What problem does this paper attempt to address?